Home > Products > CD64 & malaria antigen > Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv)

Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv)  (CAT#: BSTF-H303)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) is designed to be expressed as one chain, then assembled to a homodimer of bivalent scFv fragments and the Fc region of IgG. The anti-CD64 scFv is fused to the N-terminus of Fc via a hinge region while another anti-malaria antigen scFv is linked to the C-terminus of Fc. This scFv-Fc-scFv format has 2+2 antigen-binding valency by employing different scFv fragments. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.
Datasheet INQUIRY

Specifications

Targets
CD64 & malaria antigen
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Malaria

Targets

Target 1
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Target 2
malaria antigen
Alternative Names
malaria antigen; parasitic protozoans
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD64 & malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-Fc-scFv) (BSTF-H303). Click the button below to contact us or submit your feedback about this product.